Welcome to Our Blog: About Madison Street Company®

Madison Street Company® is comprised of four ophthalmic specialty companies:

  • Omni Eye Specialists – Providing treatment and surgical options for all vision conditions including cataracts, premium IOLs, glaucoma, corneal disease, oculoplastics, and retina. We have state-of-the art diagnostics.  All our doctors are fellowship trained in either cornea, glaucoma, plastics and retina. We work closely with your Optometrists who most likely referred you to us.  We will refer you back to your eye doctor when your condition has been treated.   We also provide after hours emergency on call care for patients.We have two main locations:  55 Madison Street, Suite 355 in Cherry Creek, and 2881 South Yosemite Street in Centennial.  We also have additional locations.  Please ask us when you make an appointment.   Call 303.377.2020 to make your appointment.
[Continue reading…]

Nutrition and Age-Related Macular Degeneration

In the United States age-related macular degeneration (AMD) is the leading cause of blindness (visual acuity < 20/200) in elderly patients[1].

Non-modifiable risk factors for disease include genetic susceptibility, race, eye color, female gender, and age. Modifiable risk factors include cigarette smoking, hypercholesterolemia, obesity, chronic exposure to ultraviolet light, and nutritional status[2]. Prevention of disease has been focused on smoking cessation, maintenance of a healthy diet, and vitamin and mineral supplementation.

[Continue reading…]

New Laser Technology for Creating LASIK Flaps

Lasik surgery was first patented in 1989. The FDA started studies at 10 different centers in the US with approval in 1998. Now there are over 700,000 LASIK procedures performed each year (wikepedia). The instrument used to separate the layers of the cornea to create a “flap” is known as the microkeratome. It was patented by Jose Barrquer in 1950. This instrument was later used for LASIK procedures starting in 1989. The microkeratome is a mechanical oscillating blade that creates an incision as it passes over the cornea. There are now multiple models of the microkeratome and several manufactures.

[Continue reading…]

Retinal Venous Occlusion

Retinal venous occlusion is among the foremost causes of sudden painless loss of vision and the second most prevalent retinal vascular disease after diabetic retinopathy. The rubric retinal venous obstructive disease includes two primary manifestations: branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). Although BRVO and CRVO differ in terms of pathophysiology and clinical course, the shared mechanisms for decreased vision include retinal edema, retinal hemorrhage, retinal ischemia, and vitreous hemorrhage. Eighty percent of retinal vein occlusions are BRVO’s[1]. Associations with BRVO include hypertension, cardiovascular disease, increased body mass index by age 20, and glaucoma[2]. The pathophysiology of BRVO typically originates in the retinal vascular anatomy wherein retinal arteries and veins share a common adventitial sheath. As arteriosclerotic changes develop in the arteries, secondary venous compression results in turbulent blood flow leading to endothelial damage and thrombus formation.

[Continue reading…]

Treating Baby Boomers & Embracing Advanced Technology IOLs

The United States experienced the largest increase in births in the country’s history after the American soldiers returned from WWII.1 Sociologists have termed those born between 1946 and 1964 as ―baby boomers.‖ This group truly changed the course and mindset of the United States.

[Continue reading…]

Genetics of Macular Degeneration

Age-related macular degeneration (AMD) continues to be the most common cause of vision loss among the elderly. The prevalence will also continue to rise with the demographic shift of our aging population. Understanding of the pathophysiology and genetics of AMD has grown dramatically in recent years. A number of specific genes have been established as major risk factors in the development and progression of AMD. Genetic polymorphisms among complement factors account for the majority. Analysis of these genetic variants, along with age and smoking history, has yielded highly predictive models of individual patient risk. These advances allow greater prognostic accuracy and will help tailor treatment and monitoring for individual patients.

[Continue reading…]